Sorafenib improves the survival of patients with advanced hepatocellular carcinoma: a meta-analysis of randomized trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Sorafenib improves the survival of patients with advanced hepatocellular carcinoma: a meta-analysis of randomized trials

Published:2010-03 Issue:3 Volume:21 Page:326-332
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Zhang Tao,Ding Xin,Wei Dong,Cheng Peng,Su Xiaomei,Liu Huanyi,Wang Daoyuan,Gao Hui

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference25 articles.

1. Global cancer statistics, 2002.;Parkin;CA Cancer J Clin,2005

2. The continuing challenge of hepatic cancer in Asia;Lai;Surgeon,2005

3. Rising incidence of hepatocellular carcinoma in the United States;El-Serag;N Engl J Med,1999

4. The history of liver surgery;Lau;J R Coll Surg Edinb,1997

5. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis;Mazzaferro;N Engl J Med,1996

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Landscape of m6A RNA methylation regulators in liver cancer and its therapeutic implications;Frontiers in Pharmacology;2024-03-13

2. Explosomes: A new modality for DEB-TACE local delivery of sorafenib: In vivo proof of sustained release;Journal of Controlled Release;2023-12

3. Effects of Voluntary Wheel Running Exercise on Chemotherapy-Impaired Cognitive and Motor Performance in Mice;International Journal of Environmental Research and Public Health;2023-04-03

4. The clinical management of hepatocellular carcinoma worldwide: A concise review and comparison of current guidelines: 2022 update;BioScience Trends;2022-02-28

5. Unique situation of hepatocellular carcinoma in Egypt: A review of epidemiology and control measures;World Journal of Gastrointestinal Oncology;2021-12-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3